Sponsor Pipeline

Shanghai Juncell Therapeutics Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
16
Active Trials
15
Recruiting
7
Disease Areas
11
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07294872
A Study of TIL in Advanced Solid Tumors (CZ)
date change Primary completion pushed: 2026-09-20 -> 2027-09-20
2026-08-06 NCT04967833
A Study of GC101 TIL in Advanced Solid Tumors (TR)
date change Primary completion pushed: 2025-12-22 -> 2027-12-22
2026-08-06 NCT04967833
A Study of GC101 TIL in Advanced Solid Tumors (TR)
date change Completion pushed: 2026-04-22 -> 2029-04-22
2026-08-06 NCT07256756
A Study of GC203 TIL in Advanced Solid Tumors (NF)
Recruitment opened
2026-08-06 NCT06473961
A Phase Ib Study of GC101 in NSCLC
date change Primary completion pushed: 2026-01-01 -> 2027-01-01
2026-08-06 NCT06473961
A Phase Ib Study of GC101 in NSCLC
date change Completion pushed: 2027-07-01 -> 2028-07-01
2026-08-06 NCT04960072
A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)
date change Primary completion pushed: 2025-12-30 -> 2027-12-30
2026-08-06 NCT04960072
A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)
date change Completion pushed: 2026-07-30 -> 2029-07-30
2026-08-06 NCT06703398
A Study of GC101 TIL in Advanced Melanoma
date change Primary completion moved earlier: 2026-07-10 -> 2026-05-12
2026-08-06 NCT06703398
A Study of GC101 TIL in Advanced Melanoma
date change Completion pushed: 2026-12-20 -> 2027-12-20
2026-08-06 NCT07560111
A Phase II Study of GC101 in NSCLC
Recruitment opened
Active Trials by Phase
Phase 2
2
Phase 1
4
Early Phase 1
10
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06703398 A Study of GC101 TIL in Advanced Melanoma Melanoma Recruiting
NCT07560111 A Phase II Study of GC101 in NSCLC Non Small Cell Lung Cancer Recruiting
Phase 1
NCT06375187 A Study of GC203 TIL in Advanced Malignant Solid Tumors Solid Tumor Recruiting
NCT06473961 A Phase Ib Study of GC101 in NSCLC Non Small Cell Lung Cancer Metastatic Recruiting
NCT07256756 A Study of GC203 TIL in Advanced Solid Tumors (NF) Solid Tumors, Adult Recruiting
NCT07294872 A Study of TIL in Advanced Solid Tumors (CZ) Solid Tumor, Adult Not Yet Recruiting
Early Phase 1
NCT05098171 A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital) Advanced Gynecologic Tumors Recruiting
NCT05098184 A Study of GC101 TIL in Advanced Melanoma (10hospital) Advanced Melanoma Recruiting
NCT05098197 A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital) Advanced Liver Cancers Recruiting
NCT05142475 A Study of GC101 TIL in Advanced Breast Cancer (10hospital) Breast Cancer Recruiting
NCT06488950 A Study of TIL in Advanced Solid Tumors (DFGD) Advanced Solid Tumor Recruiting
NCT04943913 Study of GC101 TIL in Brain Glioma (Soochow2) Glioma Recruiting
NCT04960072 A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital) Gastrointestinal Tumor Recruiting
NCT04967833 A Study of GC101 TIL in Advanced Solid Tumors (TR) Advanced Solid Tumors Recruiting
NCT05087745 A Clinical Study on TIL for the Treatment of Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT06828328 A Study of GC203 TIL in PDCA (RJ) Pancreatic Cancer Recruiting
Disease Areas
Get alerts when Shanghai Juncell Therapeutics's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free